Magnolia Eye Group offers Valeda system for select dry AMD patients
Magnolia Eye Group is offering the Valeda Light Delivery System as a treatment option for select patients with dry age-related macular degeneration.
The provider describes Valeda as the first and only FDA-authorized treatment for dry age-related macular degeneration. The treatment is non-invasive and does not involve injections.
Patients can call Magnolia Eye Group to schedule a consultation to determine whether they meet the requirements for treatment.
Source: Hernando Main Street Chamber of Commerce.





